<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Gene Therapy</title><link href="http://biotechresearchinfo.com/topic/gene-therapy" rel="alternate"></link><id>http://biotechresearchinfo.com/topic/gene-therapy</id><updated>2010-09-01T12:16:39Z</updated><entry><title>Gene therapy strengthens muscles in monkeys</title><link href="http://biotechresearchinfo.com/gene-therapy/gene-therapy-strengthens-muscles-monkeys-738218a" rel="alternate"></link><updated>2010-04-16T09:13:53Z</updated><author><name>Reuters US Online Report Science News</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/gene-therapy/gene-therapy-strengthens-muscles-monkeys-738218a/</id><summary type="html">&lt;div&gt;&lt;p&gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - A gene therapy treatment that stops the breakdown of muscle appeared safe in monkeys and may build up muscle, too, researchers reported on Wednesday.&lt;/p&gt;&lt;p&gt;The approach is being developed in the hope of treating severe muscle weakness caused by multiple sclerosis, muscular dystrophy and neurodegenerative diseases, but progress is slow in part because of fears about its safety.&lt;/p&gt;&lt;p&gt;Janaiah &lt;a title=...</summary><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Medical Technology"></category><category term="Gene Therapy"></category><category term="Wildlife"></category><category term="Mammals"></category><category term="United States"></category><category term="Columbus (Ohio)"></category><category term="Reuters Group plc"></category><category term="Nationwide Children's Hospital"></category><category term="Kota"></category><category term="Center for Gene Therapy"></category></entry><entry><title>Scientists halt brain disease with new gene therapy</title><link href="http://biotechresearchinfo.com/gene-therapy/scientists-halt-brain-disease-new-gene-therapy-732641a" rel="alternate"></link><updated>2010-04-16T09:21:03Z</updated><author><name>Reuters US Online Report Science News</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/gene-therapy/scientists-halt-brain-disease-new-gene-therapy-732641a/</id><summary type="html">&lt;div&gt;&lt;p&gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Scientists have managed to halt a rare and fatal brain disease with an experimental gene therapy technique using a deactivated version of the AIDS virus, a study published on Thursday showed.&lt;/p&gt;&lt;p&gt;The international team used a disabled form of human immunodeficiency virus (HIV) to deliver working genes to two boys with the brain disease X-linked adrenoleukodystrophy (ALD). Their success may help shape f...</summary><category term="Contagious and Infectious Diseases"></category><category term="HIV and AIDS"></category><category term="Sexual and Reproductive Health"></category><category term="Sexually Transmitted Diseases"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Medical Technology"></category><category term="Gene Therapy"></category><category term="United States"></category><category term="Reuters Group plc"></category><category term="Clinical Immunology"></category></entry><entry><title>Gene therapy beats back brain wasting disease: study</title><link href="http://biotechresearchinfo.com/gene-therapy/gene-therapy-beats-brain-wasting-disease-study-731402a" rel="alternate"></link><updated>2010-04-16T09:22:41Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/gene-therapy/gene-therapy-beats-brain-wasting-disease-study-731402a/</id><summary type="html">&lt;div&gt;&lt;p&gt;A breakthrough mix of stem cell and gene therapy halted a lethal brain-wasting illness in two young boys, and could prove effective against other genetic disorders, researchers reported Thursday.&lt;/p&gt;&lt;p&gt;The boys, both seven when treatment began in &lt;a title="France" href="/topic/France" &gt;France&lt;/a&gt;, are beset with X-linked adrenoleukodystrophy, or ALD, a hereditary brain disease that slowly strips away layers of fatty acids protecting nerve fibres in the brain.&lt;/p&gt;&lt;p&gt;Without treatment, ALD...</summary><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Medical Technology"></category><category term="Gene Therapy"></category><category term="United States"></category><category term="Europe"></category><category term="France"></category><category term="Western Europe"></category><category term="Patrick Aubourg"></category></entry><entry><title>New gene therapy halts 2 boys' rare brain disease</title><link href="http://biotechresearchinfo.com/gene-therapy/new-gene-therapy-halts-2-boys-rare-brain-disease-731307a" rel="alternate"></link><updated>2010-04-16T09:22:47Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/gene-therapy/new-gene-therapy-halts-2-boys-rare-brain-disease-731307a/</id><summary type="html">&lt;div id="subtitle"&gt;French scientists appear to halt rare brain disease in 2 boys with new gene therapy approach&lt;/div&gt;&lt;div&gt;&lt;p&gt;French scientists mixed gene therapy and bone marrow transplants in two boys to seemingly halt a brain disease that can kill by adolescence. The surprise ingredient: They disabled the HIV virus so it couldn't cause AIDS, and then used it to carry in the healthy new gene.&lt;/p&gt;&lt;p&gt;The experiment marks the first time researchers have tried that long-contemplated step in people ...</summary><category term="Contagious and Infectious Diseases"></category><category term="HIV and AIDS"></category><category term="Sexual and Reproductive Health"></category><category term="Sexually Transmitted Diseases"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Medical Technology"></category><category term="Gene Therapy"></category><category term="United States"></category><category term="Indiana University"></category><category term="Patrick Aubourg"></category><category term="Kenneth Cornetta"></category><category term="Stop ALD Foundation"></category><category term="American Society of Gene and Cell Therapy"></category></entry><entry><title>Gene therapy experiment restores sight in a few</title><link href="http://biotechresearchinfo.com/gene-therapy/gene-therapy-experiment-restores-sight-716331a" rel="alternate"></link><updated>2010-04-16T09:39:54Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/gene-therapy/gene-therapy-experiment-restores-sight-716331a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Philadelphia" href="/topic/Philadelphia" &gt;PHILADELPHIA&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Nine-year-old Corey Haas can ride his bike alone now, thanks to an experimental gene therapy that has boosted his fading vision with a single treatment.&lt;/p&gt;&lt;p&gt;The gene therapy helped improve worsening eyesight caused by a rare inherited disease called Leber congenital amaurosis, or LCA, which makes most patients blind by age 40.&lt;/p&gt;&lt;p&gt;Twelve t...</summary><category term="Eyesight and Eye Health"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Medical Technology"></category><category term="Gene Therapy"></category><category term="United States"></category><category term="Washington, DC"></category><category term="New York"></category><category term="San Francisco"></category><category term="Philadelphia"></category><category term="Europe"></category><category term="Netherlands"></category><category term="France"></category><category term="Howard Hughes Medical Institute"></category><category term="University of Pennsylvania"></category><category term="Western Europe"></category><category term="The Children's Hospital of Philadelphia"></category><category term="Reuters Group plc"></category><category term="Maggie Fox"></category><category term="John O'Callaghan"></category><category term="Nijmegen"></category><category term="Jean Bennett"></category><category term="Ethan Haas"></category><category term="Frans Cremers"></category><category term="Nancy Haas"></category><category term="Rob Collin"></category></entry><entry><title>Long-term monkey tests back Oxford's gene therapy</title><link href="http://biotechresearchinfo.com/gene-therapy/longterm-monkey-tests-oxfords-gene-therapy-704631a" rel="alternate"></link><updated>2010-04-16T09:50:28Z</updated><author><name>Reuters US Online Report Science News</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/gene-therapy/longterm-monkey-tests-oxfords-gene-therapy-704631a/</id><summary type="html">&lt;div&gt;&lt;p&gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Long-term tests on monkeys using &lt;a title="Oxford BioMedica plc" href="/topic/Oxford+BioMedica+plc" &gt;Oxford BioMedica&lt;/a&gt;'s gene therapy ProSavin suggest it can treat Parkinson's disease without causing the jerky, involuntary movements associated with current drugs, researchers said on Wednesday.&lt;/p&gt;&lt;p&gt;Parkinson's is caused by lack of the brain chemical dopamine. Standard treatment involves oral drugs th...</summary><category term="Clinical Trials"></category><category term="Parkinson's Disease"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Medical Technology"></category><category term="Gene Therapy"></category><category term="Wildlife"></category><category term="Mammals"></category><category term="United States"></category><category term="Reuters Group plc"></category><category term="Oxford BioMedica plc"></category><category term="Ben Hirschler"></category><category term="Brain and Nerve Health"></category><category term="Bechir Jarraya"></category></entry><entry><title>Gene therapy cures form of 'bubble boy disease'</title><link href="http://biotechresearchinfo.com/gene-therapy/gene-therapy-cures-form-bubble-boy-disease-134999a" rel="alternate"></link><updated>2010-04-16T17:21:12Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/gene-therapy/gene-therapy-cures-form-bubble-boy-disease-134999a/</id><summary type="html">&lt;div id="subtitle"&gt;Gene therapy cures children with 'bubble boy' disease; hope for other blood disorders seen&lt;/div&gt;&lt;div&gt;&lt;p&gt;Gene therapy seems to have cured eight of 10 children who had potentially fatal "bubble boy disease," according to a study that followed their progress for about four years after treatment. The eight patients were no longer on medication for the rare disease, which cripples the body's defenses against infection. The successful treatment is reported in Thursday's issue of the...</summary><category term="Cancer"></category><category term="Leukemia"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Medical Technology"></category><category term="Gene Therapy"></category><category term="United States"></category><category term="Israel"></category><category term="Italy"></category><category term="Europe"></category><category term="University of Southern California"></category><category term="Middle East"></category><category term="The New England Journal of Medicine"></category><category term="Houston (Texas)"></category><category term="Donald Kohn"></category><category term="David Vetter"></category><category term="Childrens Hospital Los Angeles"></category><category term="Southern Europe"></category><category term="Blood Disorders"></category></entry><entry><title>Gene Therapy May One Day Prevent AIDS&amp;#8211;Related Brain&amp;#8211;Cell Death</title><link href="http://biotechresearchinfo.com/gene-therapy/gene-therapy-day-prevent-aids238211related-brain238211cell-death-465a" rel="alternate"></link><updated>2010-04-16T17:57:41Z</updated><author><name>National Institute of Mental Health</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/gene-therapy/gene-therapy-day-prevent-aids238211related-brain238211cell-death-465a/</id><summary type="html">&lt;p&gt;Scientists have shown that gene therapy has potential for treating brain pathology triggered by the human immunodeficiency virus (HIV), which causes AIDS. Although brain damage is among the most common complications of AIDS, there is no recognized therapy for preventing the underlying HIV-induced cell death.&lt;/p&gt;&lt;p&gt;  NIMH-funded researchers &lt;a title="D.S. Strayer" href="/topic/D.S.+Strayer" &gt;Dr. D.S. Strayer&lt;/a&gt; and colleagues from &lt;a title="Thomas Jefferson University" href="/topic/Thomas+Jef...</summary><category term="Contagious and Infectious Diseases"></category><category term="HIV and AIDS"></category><category term="Sexually Transmitted Diseases"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Cognitive Science"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Medical Technology"></category><category term="Gene Therapy"></category><category term="Thomas Jefferson University"></category></entry><entry><title>Promising Results in Phase 1 Gene Therapy Trial for Blinding Disease</title><link href="http://biotechresearchinfo.com/gene-therapy/promising-results-phase-1-gene-therapy-trial-blinding-disease-1383a" rel="alternate"></link><updated>2010-04-16T17:57:13Z</updated><author><name>National Eye Institute</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/gene-therapy/promising-results-phase-1-gene-therapy-trial-blinding-disease-1383a/</id><summary type="html">&lt;p&gt;Three young adults with an inherited form of blindness showed evidence of improved day and night vision following a specialized gene transfer procedure in a phase 1 clinical trial funded by the &lt;a title="National Eye Institute" href="/topic/National+Eye+Institute" &gt;National Eye Institute (NEI)&lt;/a&gt;, part of the &lt;a title="National Institutes of Health" href="/topic/National+Institutes+of+Health" &gt;National Institutes of Health&lt;/a&gt;. In addition no adverse effects from the therapy were reported. T...</summary><category term="Eyesight and Eye Health"></category><category term="Clinical Trials"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Medical Technology"></category><category term="Gene Therapy"></category><category term="Philadelphia"></category><category term="National Institutes of Health"></category><category term="National Eye Institute"></category><category term="National Academy of Sciences"></category><category term="University of Pennsylvania"></category><category term="The New England Journal of Medicine"></category><category term="Gainesville"></category><category term="University of Florida"></category></entry><entry><title>Researchers Report Progress in Salivary Gland Gene Transfer</title><link href="http://biotechresearchinfo.com/gene-therapy/researchers-report-progress-salivary-gland-gene-transfer-1755a" rel="alternate"></link><updated>2010-04-16T17:57:00Z</updated><author><name>National Institute of Dental and Craniofacial Research</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/gene-therapy/researchers-report-progress-salivary-gland-gene-transfer-1755a/</id><summary type="html">&lt;p&gt;Two years ago, scientists reported exciting news in the development of gene therapy for the salivary gland. They had constructed a new version of a gene-carrying vehicle, or vector, that functioned well in the salivary glands of mice for several weeks. Most significantly, the vector - a stripped down, bioengineered version of the harmless adeno-associated virus (AAV) - had done so without triggering a sustained immune response, a common setback in gene therapy experiments.&lt;/p&gt;&lt;p&gt;  Left unansw...</summary><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Medical Technology"></category><category term="Gene Therapy"></category><category term="National Institute of Dental and Craniofacial Research"></category><category term="National Academy of Sciences"></category></entry><entry><title>Gene Transfer Successful in Mouse Model of Limb-Girdle Muscular Dystrophy</title><link href="http://biotechresearchinfo.com/gene-therapy/gene-transfer-successful-mouse-model-limbgirdle-muscular-dystrophy-1209a" rel="alternate"></link><updated>2010-09-01T12:16:39Z</updated><author><name>National Institute of Arthritis and Musculoskeletal and Skin Diseases</name></author><id>tag:biotechresearchinfo.com,2010-09-01:/gene-therapy/gene-transfer-successful-mouse-model-limbgirdle-muscular-dystrophy-1209a/</id><summary type="html">&lt;p&gt;Gene Transfer Successful in Mouse Model of Limb-Girdle Muscular Dystrophy . Scientists have found that progression of limb-girdle muscular dystrophy type 2D (LGMD-2D) can be prevented over the long term in mice after transferring a correctly functioning form of the alpha-sarcoglycan gene (SGCA) to their muscle tissue. The research was partly supported by the &lt;a title="National Institute of Arthritis and Musculoskeletal and Skin Diseases" href="/topic/National+Institute+of+Arthritis+and+Muscul...</summary><category term="Domestic Policy"></category><category term="Social Policy"></category><category term="Health Care Policy"></category><category term="Health Care Issues"></category><category term="Medical Treatments and Procedures"></category><category term="Muscular Dystrophies"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Medical Technology"></category><category term="Gene Therapy"></category><category term="University of Iowa"></category><category term="National Institute of Arthritis and Musculoskeletal and Skin Diseases"></category><category term="Kevin Campbell"></category><category term="University of Florida Health Science Center"></category><category term="Skin Health"></category><category term="Genetic Engineering"></category><category term="Muscle and Skeletal Health"></category></entry></feed>
